Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Grouped Amorphous Calcifications at Mammography: Frequently Atypical but Rarely Associated with Aggressive Malignancy.

Oligane HC, Berg WA, Bandos AI, Chen SS, Sohrabi S, Anello M, Zuley ML.

Radiology. 2018 Jun 19:172406. doi: 10.1148/radiol.2018172406. [Epub ahead of print]

PMID:
29916773
2.

Radiogenomics of High-Grade Serous Ovarian Cancer: Multireader Multi-Institutional Study from the Cancer Genome Atlas Ovarian Cancer Imaging Research Group.

Vargas HA, Huang EP, Lakhman Y, Ippolito JE, Bhosale P, Mellnick V, Shinagare AB, Anello M, Kirby J, Fevrier-Sullivan B, Freymann J, Jaffe CC, Sala E.

Radiology. 2017 Nov;285(2):482-492. doi: 10.1148/radiol.2017161870. Epub 2017 Jun 22.

PMID:
28641043
3.

Genetic diversity and conservation status of managed vicuña (Vicugna vicugna) populations in Argentina.

Anello M, Daverio MS, Romero SR, Rigalt F, Silbestro MB, Vidal-Rioja L, Di Rocco F.

Genetica. 2016 Feb;144(1):85-97. doi: 10.1007/s10709-015-9880-z. Epub 2016 Feb 3.

PMID:
26842726
4.

Discovery of 2-[1-(4,4-Difluorocyclohexyl)piperidin-4-yl]-6-fluoro-3-oxo-2,3-dihydro-1H-isoindole-4-carboxamide (NMS-P118): A Potent, Orally Available, and Highly Selective PARP-1 Inhibitor for Cancer Therapy.

Papeo G, Posteri H, Borghi D, Busel AA, Caprera F, Casale E, Ciomei M, Cirla A, Corti E, D'Anello M, Fasolini M, Forte B, Galvani A, Isacchi A, Khvat A, Krasavin MY, Lupi R, Orsini P, Perego R, Pesenti E, Pezzetta D, Rainoldi S, Riccardi-Sirtori F, Scolaro A, Sola F, Zuccotto F, Felder ER, Donati D, Montagnoli A.

J Med Chem. 2015 Sep 10;58(17):6875-98. doi: 10.1021/acs.jmedchem.5b00680. Epub 2015 Aug 26.

PMID:
26222319
5.

A common neural code for similar conscious experiences in different individuals.

Naci L, Cusack R, Anello M, Owen AM.

Proc Natl Acad Sci U S A. 2014 Sep 30;111(39):14277-82. doi: 10.1073/pnas.1407007111. Epub 2014 Sep 15.

6.

A blind human expert echolocator shows size constancy for objects perceived by echoes.

Milne JL, Anello M, Goodale MA, Thaler L.

Neurocase. 2015;21(4):465-70. doi: 10.1080/13554794.2014.922994. Epub 2014 May 29.

PMID:
24874426
7.

Prevention by metformin of alterations induced by chronic exposure to high glucose in human islet beta cells is associated with preserved ATP/ADP ratio.

Masini M, Anello M, Bugliani M, Marselli L, Filipponi F, Boggi U, Purrello F, Occhipinti M, Martino L, Marchetti P, De Tata V.

Diabetes Res Clin Pract. 2014 Apr;104(1):163-70. doi: 10.1016/j.diabres.2013.12.031. Epub 2014 Jan 3.

PMID:
24462282
8.

Impact of and interaction between the availability of prior examinations and DBT on the interpretation of negative and benign mammograms.

Hakim CM, Anello MI, Cohen CS, Ganott MA, Lu AH, Perrin RL, Shah R, Lee Spangler M, Bandos AI, Gur D.

Acad Radiol. 2014 Apr;21(4):445-9. doi: 10.1016/j.acra.2013.10.015. Epub 2013 Dec 5.

9.

Discovery and optimization of pyrrolo[1,2-a]pyrazinones leads to novel and selective inhibitors of PIM kinases.

Casuscelli F, Ardini E, Avanzi N, Casale E, Cervi G, D'Anello M, Donati D, Faiardi D, Ferguson RD, Fogliatto G, Galvani A, Marsiglio A, Mirizzi DG, Montemartini M, Orrenius C, Papeo G, Piutti C, Salom B, Felder ER.

Bioorg Med Chem. 2013 Dec 1;21(23):7364-80. doi: 10.1016/j.bmc.2013.09.054. Epub 2013 Oct 2.

PMID:
24139169
10.

Rationale of excisional biopsy after the diagnosis of benign radial scar on core biopsy: a single institutional outcome analysis.

Andacoglu O, Kanbour-Shakir A, Teh YC, Bonaventura M, Ozbek U, Anello M, Ganott M, Kelley J, Dirican A, Soran A.

Am J Clin Oncol. 2013 Feb;36(1):7-11. doi: 10.1097/COC.0b013e3182354a3f.

PMID:
22134516
11.

Dose reduction in digital breast tomosynthesis (DBT) screening using synthetically reconstructed projection images: an observer performance study.

Gur D, Zuley ML, Anello MI, Rathfon GY, Chough DM, Ganott MA, Hakim CM, Wallace L, Lu A, Bandos AI.

Acad Radiol. 2012 Feb;19(2):166-71. doi: 10.1016/j.acra.2011.10.003. Epub 2011 Nov 18.

12.

Myocardial parvovirus B19 persistence: lack of association with clinicopathologic phenotype in adults with heart failure.

Stewart GC, Lopez-Molina J, Gottumukkala RV, Rosner GF, Anello MS, Hecht JL, Winters GL, Padera RF, Baughman KL, Lipes MA.

Circ Heart Fail. 2011 Jan;4(1):71-8. doi: 10.1161/CIRCHEARTFAILURE.110.958249. Epub 2010 Nov 19.

13.

Cdc7 kinase inhibitors: 5-heteroaryl-3-carboxamido-2-aryl pyrroles as potential antitumor agents. 1. Lead finding.

Menichincheri M, Albanese C, Alli C, Ballinari D, Bargiotti A, Caldarelli M, Ciavolella A, Cirla A, Colombo M, Colotta F, Croci V, D'Alessio R, D'Anello M, Ermoli A, Fiorentini F, Forte B, Galvani A, Giordano P, Isacchi A, Martina K, Molinari A, Moll JK, Montagnoli A, Orsini P, Orzi F, Pesenti E, Pillan A, Roletto F, Scolaro A, Tatò M, Tibolla M, Valsasina B, Varasi M, Vianello P, Volpi D, Santocanale C, Vanotti E.

J Med Chem. 2010 Oct 28;53(20):7296-315. doi: 10.1021/jm100504d.

PMID:
20873740
14.

Thieno[3,2-c]pyrazoles: a novel class of Aurora inhibitors with favorable antitumor activity.

Bindi S, Fancelli D, Alli C, Berta D, Bertrand JA, Cameron AD, Cappella P, Carpinelli P, Cervi G, Croci V, D'Anello M, Forte B, Giorgini ML, Marsiglio A, Moll J, Pesenti E, Pittalà V, Pulici M, Riccardi-Sirtori F, Roletto F, Soncini C, Storici P, Varasi M, Volpi D, Zugnoni P, Vianello P.

Bioorg Med Chem. 2010 Oct 1;18(19):7113-20. doi: 10.1016/j.bmc.2010.07.048. Epub 2010 Jul 25.

PMID:
20817473
15.

Patient expectations from implantable defibrillators to prevent death in heart failure.

Stewart GC, Weintraub JR, Pratibhu PP, Semigran MJ, Camuso JM, Brooks K, Tsang SW, Anello MS, Nguyen VT, Lewis EF, Nohria A, Desai AS, Givertz MM, Stevenson LW.

J Card Fail. 2010 Feb;16(2):106-13. doi: 10.1016/j.cardfail.2009.09.003. Epub 2009 Nov 4.

16.

Clinical phenotype and beta-cell autoimmunity in Italian patients with adult-onset diabetes.

Genovese S, Bazzigaluppi E, Gonçalves D, Ciucci A, Cavallo MG, Purrello F, Anello M, Rotella CM, Bardini G, Vaccaro O, Riccardi G, Travaglini P, Morenghi E, Bosi E, Pozzilli P.

Eur J Endocrinol. 2006 Mar;154(3):441-7.

17.

Cellular and molecular effects of protons: apoptosis induction and potential implications for cancer therapy.

Di Pietro C, Piro S, Tabbì G, Ragusa M, Di Pietro V, Zimmitti V, Cuda F, Anello M, Consoli U, Salinaro ET, Caruso M, Vancheri C, Crimi N, Sabini MG, Cirrone GA, Raffaele L, Privitera G, Pulvirenti A, Giugno R, Ferro A, Cuttone G, Lo Nigro S, Purrello R, Purrello F, Purrello M.

Apoptosis. 2006 Jan;11(1):57-66.

PMID:
16374542
18.

The effect of hypoxic-ischemic brain injury in perinatal rats on the abundance and proteolysis of brevican and NG2.

Aya-ay J, Mayer J, Eakin AK, Muffly BG, Anello M, Sandy JD, Gottschall PE.

Exp Neurol. 2005 May;193(1):149-62.

PMID:
15817274
19.

Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients.

Anello M, Lupi R, Spampinato D, Piro S, Masini M, Boggi U, Del Prato S, Rabuazzo AM, Purrello F, Marchetti P.

Diabetologia. 2005 Feb;48(2):282-9. Epub 2005 Jan 15.

PMID:
15654602
20.

Glucosamine-induced alterations of mitochondrial function in pancreatic beta-cells: possible role of protein glycosylation.

Anello M, Spampinato D, Piro S, Purrello F, Rabuazzo AM.

Am J Physiol Endocrinol Metab. 2004 Oct;287(4):E602-8. Epub 2004 May 18.

21.

Chronic exposure to free fatty acids or high glucose induces apoptosis in rat pancreatic islets: possible role of oxidative stress.

Piro S, Anello M, Di Pietro C, Lizzio MN, Patanè G, Rabuazzo AM, Vigneri R, Purrello M, Purrello F.

Metabolism. 2002 Oct;51(10):1340-7.

PMID:
12370856
23.

Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated.

Lupi R, Dotta F, Marselli L, Del Guerra S, Masini M, Santangelo C, Patané G, Boggi U, Piro S, Anello M, Bergamini E, Mosca F, Di Mario U, Del Prato S, Marchetti P.

Diabetes. 2002 May;51(5):1437-42.

24.

Insulin secretory function is impaired in isolated human islets carrying the Gly(972)-->Arg IRS-1 polymorphism.

Marchetti P, Lupi R, Federici M, Marselli L, Masini M, Boggi U, Del Guerra S, Patanè G, Piro S, Anello M, Bergamini E, Purrello F, Lauro R, Mosca F, Sesti G, Del Prato S.

Diabetes. 2002 May;51(5):1419-24.

25.

Chronic exposure to high leucine impairs glucose-induced insulin release by lowering the ATP-to-ADP ratio.

Anello M, Ucciardello V, Piro S, Patané G, Frittitta L, Calabrese V, Giuffrida Stella AM, Vigneri R, Purrello F, Rabuazzo AM.

Am J Physiol Endocrinol Metab. 2001 Nov;281(5):E1082-7.

26.

[ATP-dependent potassium channels and insulin secretion: essential but not sufficient role].

Henquin JC, Anello M, Sato Y.

Journ Annu Diabetol Hotel Dieu. 2000:13-24. Review. French. No abstract available.

PMID:
10932865
27.
28.

Exposure to glibenclamide increases rat beta cells sensitivity to glucose.

Patanè G, Piro S, Anello M, Rabuazzo AM, Vigneri R, Purrello F.

Br J Pharmacol. 2000 Mar;129(5):887-92.

30.
31.

Efficacy of combined treatments in NIDDM patients with secondary failure to sulphonylureas. Is it predictable?

Trischitta V, Italia S, Raimondo M, Guardabasso V, Licciardello C, Runello F, Mazzarino S, Sangiorgi L, Anello M, Vigneri R.

J Endocrinol Invest. 1998 Dec;21(11):744-7.

PMID:
9972673
32.

Hexokinase shift to mitochondria is associated with an increased sensitivity to glucose in rat pancreatic islets.

Rabuazzo AM, Patanè G, Anello M, Piro S, Vigneri R, Purrello F.

Diabetes. 1997 Jul;46(7):1148-52.

PMID:
9200649
33.

Effects of prolonged glucose stimulation on pancreatic beta cells: from increased sensitivity to desensitization.

Purrello F, Rabuazzo AM, Anello M, Patanè G.

Acta Diabetol. 1996 Dec;33(4):253-6. Review.

PMID:
9033963
34.

Fast reversibility of glucose-induced desensitization in rat pancreatic islets. Evidence for an involvement of ionic fluxes.

Anello M, Rabuazzo AM, Degano C, Caltabiano V, Patanè G, Vigneri R, Purrello F.

Diabetes. 1996 Apr;45(4):502-6.

PMID:
8603773
35.

Interleukin-1 beta inhibition of insulin release in rat pancreatic islets: possible involvement of G-proteins in the signal transduction pathway.

Rabuazzo AM, Buscema M, Caltabiano V, Anello M, Degano C, Patanè G, Vigneri R, Purrello F.

Diabetologia. 1995 Jul;38(7):779-84.

PMID:
7556978
36.

Insulin receptor tyrosine-kinase activity is altered in both muscle and adipose tissue from non-obese normoglycaemic insulin-resistant subjects.

Grasso G, Frittitta L, Anello M, Russo P, Sesti G, Trischitta V.

Diabetologia. 1995 Jan;38(1):55-61.

PMID:
7744230
37.

Inhibition of the high-affinity glucose transporter GLUT 1 affects the sensitivity to glucose in a hamster-derived pancreatic beta cell line (HIT).

Rabuazzo AM, Buscema M, Vinci C, Caltabiano V, Anello M, Vigneri R, Purrello F.

Diabetologia. 1993 Nov;36(11):1204-7.

PMID:
8270137
38.

Bacteriophage T7 late promoters with point mutations: quantitative footprinting and in vivo expression.

Chapman KA, Gunderson SI, Anello M, Wells RD, Burgess RR.

Nucleic Acids Res. 1988 May 25;16(10):4511-24. No abstract available.

39.

Nursing and the changing scene.

Anello M.

Nurs Leadersh. 1981 Sep;4(3):19-24. No abstract available.

PMID:
6912409
40.

A systematic approach to curriculum revision.

Gordon M, Anello M.

Nurs Outlook. 1974 May;22(5):306-10. No abstract available.

PMID:
4493728
41.

[Responsibility for change and innovation in professional nursing].

Anello M.

Ahot Beyisrael. 1970 Jun;16(74):49-50. Hebrew. No abstract available.

PMID:
5203316
42.

The challenge of change in society for nursing.

Anello M.

Bull Mass Nurses Assoc. 1970 Spring;39(1):4-8. No abstract available.

PMID:
5199625
43.

Responsibility for change and innovation in professional nursing.

Anello M.

Int Nurs Rev. 1969;16(3):208-21. No abstract available.

PMID:
5193746

Supplemental Content

Loading ...
Support Center